Thanks to our patient registry, the Ataxia Charlevoix-Saguenay Foundation is now connected with patients and families in 41 countries across the globe. From Canada to Europe, the United States and beyond, individuals affected by ARSACS are part of a growing international community.
This global reach is essential. Our registry helps researchers better understand the disease, identify patients for upcoming clinical trials, and accelerate the development of treatments.
